Update: 14.03.2021
Last week: 9 week 2022 (28.02.2022 - 6.03.2022)
Last full month: Feb 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | |||||||||
| WoW | 3 592 | 24.7% | 58.4% | -0.2 | 1 672 573 | 29.5% | 84.3% | 0 | 25.1% |
| MoM | 11 577 | 16.9% | 55.7% | 4.2 | 5 204 099 | 19.8% | 82.7% | 2.8 | 8.1% |
| YTD | 22 714 | 7.2% | 51.0% | -2.9 | 10 180 652 | 35.3% | 76.8% | 1.9 | 13.3% |
| MAT | 118 787 | -21.7% | 54.8% | -6.7 | 48 298 627 | 3.6% | 80.4% | -0.7 | -12.1% |
| CAPSICAM | |||||||||
| WoW | 55 140 | 25.4% | 3.0% | -0.7 | 23 558 814 | 30.1% | 2.7% | -1 | 54.9% |
| MoM | 184 740 | -6.2% | 3.7% | -0.2 | 75 707 986 | -6.3% | 3.8% | -0.3 | -1.2% |
| YTD | 381 104 | -9.9% | 6.7% | -0.5 | 156 995 174 | -11.8% | 6.8% | -1.7 | -3.1% |
| MAT | 2 086 844 | -20.6% | 6.7% | -0.7 | 855 659 980 | -12.8% | 7.1% | -1 | -12.3% |
| MILDRONATE | |||||||||
| WoW | 202 142 | 59.8% | 23.2% | 0.7 | 117 534 769 | 87.1% | 22.7% | 1 | 54.9% |
| MoM | 507 422 | 17.9% | 21.8% | 1 | 242 156 427 | 38.3% | 20.6% | 2.7 | 12.5% |
| YTD | 1 018 262 | 27.0% | 15.5% | 1.8 | 481 752 092 | 40.9% | 15.3% | 2.2 | 12.3% |
| MAT | 5 018 000 | 11.4% | 16.8% | 2.6 | 2 072 772 436 | 16.3% | 15.0% | 2.1 | -5.9% |
| SULFARGIN | |||||||||
| WoW | 4 086 | 21.8% | 0.7% | -0.2 | 2 044 022 | 25.6% | 0.9% | -0.4 | 54.8% |
| MoM | 14 059 | 2.0% | 1.0% | 0 | 6 756 585 | 0.2% | 1.3% | 0 | 2.0% |
| YTD | 28 120 | 6.5% | 0.8% | 0.1 | 13 658 359 | 10.6% | 1.2% | 0.2 | -6.1% |
| MAT | 165 661 | -20.2% | 0.8% | -0.1 | 81 066 416 | -8.7% | 1.2% | 0 | -10.8% |
| VIPROSAL | |||||||||
| WoW | 43 906 | 56.2% | 4.4% | 0.1 | 18 719 558 | 67.6% | 4.1% | -0.3 | 52.7% |
| MoM | 122 479 | 0.5% | 4.5% | 0.1 | 48 514 619 | 1.0% | 4.5% | 0 | -1.7% |
| YTD | 251 919 | 38.0% | 4.1% | 1.2 | 100 685 805 | 42.8% | 4.1% | 0.9 | -2.8% |
| MAT | 1 317 726 | -4.6% | 3.9% | 0.3 | 503 366 451 | 2.8% | 3.9% | 0.1 | -11.9% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 3 592 | 24.7% | 58.4% | -0.2 | 1 672 573 | 29.5% | 84.3% | 0 | 25.1% |
| KAPSIKAM | 55 140 | 25.4% | 3.0% | -0.7 | 23 558 814 | 30.1% | 2.7% | -1 | 54.9% |
| MILDRONATE | 202 142 | 59.8% | 23.2% | 0.7 | 117 534 769 | 87.1% | 22.7% | 1 | 54.9% |
| SULFARGIN | 4 086 | 21.8% | 0.7% | -0.2 | 2 044 022 | 25.6% | 0.9% | -0.4 | 54.8% |
| VIPROSAL | 43 906 | 56.2% | 4.4% | 0.1 | 18 719 558 | 67.6% | 4.1% | -0.3 | 52.7% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 11 577 | 16.9% | 55.7% | 4.2 | 5 204 099 | 19.8% | 82.7% | 2.8 | 8.1% |
| KAPSIKAM | 184 740 | -6.2% | 3.7% | -0.2 | 75 707 986 | -6.3% | 3.8% | -0.3 | -1.2% |
| MILDRONATE | 507 422 | 17.9% | 21.8% | 1 | 242 156 427 | 38.3% | 20.6% | 2.7 | 12.5% |
| SULFARGIN | 14 059 | 2.0% | 1.0% | 0 | 6 756 585 | 0.2% | 1.3% | 0 | 2.0% |
| VIPROSAL | 122 479 | 0.5% | 4.5% | 0.1 | 48 514 619 | 1.0% | 4.5% | 0 | -1.7% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 22 714 | 7.2% | 51.0% | -2.9 | 10 180 652 | 35.3% | 76.8% | 1.9 | 13.3% |
| KAPSIKAM | 381 104 | -9.9% | 6.7% | -0.5 | 156 995 174 | -11.8% | 6.8% | -1.7 | -3.1% |
| MILDRONATE | 1 018 262 | 27.0% | 15.5% | 1.8 | 481 752 092 | 40.9% | 15.3% | 2.2 | 12.3% |
| SULFARGIN | 28 120 | 6.5% | 0.8% | 0.1 | 13 658 359 | 10.6% | 1.2% | 0.2 | -6.1% |
| VIPROSAL | 251 919 | 38.0% | 4.1% | 1.2 | 100 685 805 | 42.8% | 4.1% | 0.9 | -2.8% |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat.Vol, Change |
|---|---|---|---|---|---|---|---|---|---|
| APILAC | 118 787 | -21.7% | 54.8% | -6.7 | 48 298 627 | 3.6% | 80.4% | -0.7 | -12.1% |
| KAPSIKAM | 2 086 844 | -20.6% | 6.7% | -0.7 | 855 659 980 | -12.8% | 7.1% | -1 | -12.3% |
| MILDRONATE | 5 018 000 | 11.4% | 16.8% | 2.6 | 2 072 772 436 | 16.3% | 15.0% | 2.1 | -5.9% |
| SULFARGIN | 165 661 | -20.2% | 0.8% | -0.1 | 81 066 416 | -8.7% | 1.2% | 0 | -10.8% |
| VIPROSAL | 1 317 726 | -4.6% | 3.9% | 0.3 | 503 366 451 | 2.8% | 3.9% | 0.1 | -11.9% |
Abbreviations
WoW - Week Over Week Change = Sales of the last week / Sales of the previous week - 1
MoM - Month Over Month Change = Sales of the last full month / Sales of the previous full month - 1
YTD - Year to Date - a period of time beginning the first day of the current calendar year up to the current date
MAT - Moving Annual Total - a period, being any 12 month period ending on the last week
MS - Market Share
Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs